CLEAR-CELL EPITHELIAL OVARIAN-CANCER (MESONEPHROID) - BAD PROGNOSIS ONLY IN EARLY STAGES
CLEAR-CELL EPITHELIAL OVARIAN-CANCER (MESONEPHROID) - BAD PROGNOSIS ONLY IN EARLY STAGES
复制标题
DOI：
10.1006/gyno.1993.1117
复制
发表时间：
1993-05-01
影响因子：
4.7
通讯作者：
WILTSHAW, E
中科院分区：
文献类型：
--
作者：
OBRIEN, MER;SCHOFIELD, JB;WILTSHAW, E
透明细胞卵巢癌占该中心所有卵巢癌病例的4.5%; 43%的患者表现为I期疾病。晚期患者（II-IV期）的分期并不比其他亚型的上皮性肿瘤差，但I期患者在5年（P< 0.05）和10年（P< 0.02）时的分期明显更差。年轻（<60岁）、晚期和存在血管浸润是独立的不良预后因素，而存在主要（>75%）乳头状或管状囊性形态学模式独立地预测较好的预后。
Clear cell ovarian carcinoma accounts for 4.5% of all cases of ovarian cancer at this center; 43% of patients presented with stage I disease. Stage for stage patients with advanced disease (II-IV) did no worse than other subtypes of epithelial tumors but patients with stage I disease did significantly worse at both 5 (P< 0.05) and 10 years (P< 0.02). Young age (<60 years), advanced stage, and the presence of vascular invasion are independently poor prognostic factors, while the presence of a predominantly (>75%) papillary or tubulocystic morphological pattern independently predicts a better prognosis.